These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 18379501)
1. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]. Serdiuk AV; Levitskiĭ GN; Miasoedov NF; Skvortsova VI Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):29-39. PubMed ID: 18379501 [TBL] [Abstract][Full Text] [Related]
2. [The study of denervation-reinnervation process in motor neuron disease and benign neuron disorders]. Serdiuk AV; Levitskiĭ GN; Skvortsova VI Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):37-43. PubMed ID: 16548373 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]. Polunin GS; Nurieva SM; Baiandin DL; Sheremet NL; Andreeva LA Vestn Oftalmol; 2000; 116(1):15-8. PubMed ID: 10741256 [TBL] [Abstract][Full Text] [Related]
4. [Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone]. Kurysheva NI; Shpak AA; Ioĭleva EE; Galanter LI; Nagornova ND; Shubina NIu; Shlyshalova NN Vestn Oftalmol; 2001; 117(4):5-8. PubMed ID: 11569188 [TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Gusev EI; Skvortsova VI; Miasoedov NF; Nezavibat'ko VN; Zhuravleva EIu; Vanichkin AV Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):26-34. PubMed ID: 11517472 [TBL] [Abstract][Full Text] [Related]
7. [The comparison of neuroprotective action of antibodies to glutamate and drug preparation semax in the focal ischemic damage of the brain prefrontal cortex of rats]. Romanova GA; Shakova FM; Davydova TV Patol Fiziol Eksp Ter; 2012; (3):62-7. PubMed ID: 23072114 [TBL] [Abstract][Full Text] [Related]
8. [An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases]. Sheremet NL; Polunin GS; Ovchinnikov AN; Kamenskiĭ AA; Levitskaia NG; Andreeva LA; Alfeeva LIu; Nagaev IIu Vestn Oftalmol; 2004; 120(6):25-7. PubMed ID: 15678666 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy. Gawel M; Jamrozik Z; Szmidt-Salkowska E; Slawek J; Gawel D; Rowińska-Marcińska K; Kaminska A J Neurol Sci; 2013 Jan; 324(1-2):136-9. PubMed ID: 23146616 [TBL] [Abstract][Full Text] [Related]
10. The reorganisation of motor units in different motor neuron disorders. Emeryk-Szajewska B; Kopeć J; Karwańska A Electromyogr Clin Neurophysiol; 2003; 43(1):23-31. PubMed ID: 12613137 [TBL] [Abstract][Full Text] [Related]
11. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Gusev EI; Martynov MY; Kostenko EV; Petrova LV; Bobyreva SN Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3. Vyp. 2):61-68. PubMed ID: 29798983 [TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system]. Levitskaia NG; Sebentsova EA; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF Ross Fiziol Zh Im I M Sechenova; 2002 Nov; 88(11):1369-77. PubMed ID: 12587264 [TBL] [Abstract][Full Text] [Related]
14. The reorganization of motor units in motor neuron disease. Emeryk-Szajewska B; Kopéc J; Karwanska A Muscle Nerve; 1997 Mar; 20(3):306-15. PubMed ID: 9052809 [TBL] [Abstract][Full Text] [Related]
15. Paraspinal and limb motor neuron involvement within homologous spinal segments in ALS. de Carvalho MA; Pinto S; Swash M Clin Neurophysiol; 2008 Jul; 119(7):1607-13. PubMed ID: 18468480 [TBL] [Abstract][Full Text] [Related]
16. MRI of peripheral nerve degeneration and regeneration: correlation with electrophysiology and histology. Bendszus M; Wessig C; Solymosi L; Reiners K; Koltzenburg M Exp Neurol; 2004 Jul; 188(1):171-7. PubMed ID: 15191813 [TBL] [Abstract][Full Text] [Related]
17. Interpretation of electrodiagnostic findings in sporadic progressive muscular atrophy. Visser J; de Visser M; Van den Berg-Vos RM; Van den Berg LH; Wokke JH; de Jong JM; Franssen H J Neurol; 2008 Jun; 255(6):903-9. PubMed ID: 18484238 [TBL] [Abstract][Full Text] [Related]
18. Long-term delivery of FGF-6 changes the fiber type and fatigability of muscle reinnervated from embryonic neurons transplanted into adult rat peripheral nerve. Grumbles RM; Casella GT; Rudinsky MJ; Wood PM; Sesodia S; Bent M; Thomas CK J Neurosci Res; 2007 Jul; 85(9):1933-42. PubMed ID: 17492788 [TBL] [Abstract][Full Text] [Related]
19. Effects of semax against the background of dopaminergic receptor blockade with haloperidol. Sebentsova EA; Levitskaya NG; Andreeva LA; Alfeeva LY; Kamenskii AA; Myasoedov NF Bull Exp Biol Med; 2006 Feb; 141(2):170-4. PubMed ID: 16984088 [TBL] [Abstract][Full Text] [Related]
20. [Use of semax at a follow-up of patients with posthypoxic encephalopathy]. Alekseeva GV; Bottaev NA; Goroshkova VV Anesteziol Reanimatol; 1999; (1):40-3. PubMed ID: 10199046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]